Ubs Group Ag Orgenesis Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$0.39 - $0.63 $2,446 - $3,951
6,273 New
6,273 $3,000
Q4 2023

Feb 09, 2024
BUY
$0.44 - $0.96 $454 - $991
1,033 Added 1541.79%
1,100 $0
Q3 2023

Nov 09, 2023
SELL
$0.41 - $1.4 $177 - $604
-432 Reduced 86.57%
67 $0
Q2 2023

Aug 11, 2023
BUY
$1.01 - $1.44 $341 - $486
338 Added 209.94%
499 $0
Q1 2023

May 12, 2023
SELL
$1.18 - $2.59 $6,723 - $14,757
-5,698 Reduced 97.25%
161 $0
Q4 2022

Feb 08, 2023
BUY
$1.18 - $2.24 $3,444 - $6,538
2,919 Added 99.29%
5,859 $11,000
Q3 2022

Nov 10, 2022
SELL
$1.38 - $2.38 $499 - $861
-362 Reduced 10.96%
2,940 $4,000
Q2 2022

Aug 10, 2022
BUY
$1.8 - $3.74 $5,943 - $12,349
3,302 New
3,302 $8,000
Q1 2022

May 16, 2022
SELL
$2.31 - $3.72 $21,275 - $34,261
-9,210 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$2.61 - $4.9 $24,035 - $45,124
9,209 Added 920900.0%
9,210 $27,000
Q3 2021

Nov 15, 2021
SELL
$4.6 - $5.44 $3,804 - $4,498
-827 Reduced 99.88%
1 $0
Q2 2021

Aug 13, 2021
SELL
$4.19 - $5.88 $17,438 - $24,472
-4,162 Reduced 83.41%
828 $4,000
Q1 2021

May 12, 2021
BUY
$4.77 - $8.08 $4,760 - $8,063
998 Added 25.0%
4,990 $29,000
Q4 2020

Feb 11, 2021
BUY
$4.4 - $5.63 $11,180 - $14,305
2,541 Added 175.12%
3,992 $18,000
Q3 2020

Nov 12, 2020
SELL
$4.75 - $5.99 $21,465 - $27,068
-4,519 Reduced 75.7%
1,451 $7,000
Q2 2020

Jul 31, 2020
BUY
$3.6 - $7.84 $19,108 - $41,614
5,308 Added 801.81%
5,970 $36,000
Q1 2020

May 01, 2020
SELL
$2.76 - $5.44 $792 - $1,561
-287 Reduced 30.24%
662 $2,000
Q4 2019

Feb 14, 2020
SELL
$2.6 - $4.66 $6,094 - $10,923
-2,344 Reduced 71.18%
949 $4,000
Q3 2019

Nov 14, 2019
BUY
$4.18 - $4.85 $2,863 - $3,322
685 Added 26.27%
3,293 $14,000
Q2 2019

Aug 14, 2019
BUY
$3.86 - $5.2 $5,990 - $8,070
1,552 Added 146.97%
2,608 $11,000
Q1 2019

May 14, 2019
SELL
$4.28 - $5.6 $856 - $1,120
-200 Reduced 15.92%
1,056 $6,000
Q4 2018

Feb 14, 2019
SELL
$3.88 - $7.46 $20,024 - $38,501
-5,161 Reduced 80.43%
1,256 $6,000
Q3 2018

Nov 14, 2018
BUY
$5.3 - $8.66 $33,713 - $55,086
6,361 Added 11358.93%
6,417 $35,000
Q2 2018

Aug 14, 2018
SELL
$8.36 - $10.72 $3,653 - $4,684
-437 Reduced 88.64%
56 $0
Q1 2018

May 15, 2018
BUY
$5.0 - $14.68 $2,465 - $7,237
493 New
493 $6,000

Others Institutions Holding ORGS

# of Institutions
2
Shares Held
134K
Call Options Held
0
Put Options Held
0
View Full List

About Orgenesis Inc.

ORGS Quotes by TradingView
  • Ticker ORGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,545,800
  • Market Cap $28.1M
  • Description
  • Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...
More about ORGS
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email